单位：[1]Chinese Acad Med Sci & Peking Union Med Coll, Mol Pathol Res Ctr, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China[3]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[4]Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China[5]Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China[6]Fudan Univ, Inst Pathol, Shanghai, Peoples R China[7]Sun Yat Sen Univ, Dept Mol Diagnost, Ctr Canc, Guangzhou, Peoples R China[8]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Peoples R China
第一作者单位：[1]Chinese Acad Med Sci & Peking Union Med Coll, Mol Pathol Res Ctr, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Wu Huanwen,Xu Binghe,Gao Qinglei,et al.Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China (vol 24, pg 715, 2020)[J].MOLECULAR DIAGNOSIS & THERAPY.2021,25(2):267-268.doi:10.1007/s40291-021-00512-y.
APA：
Wu, Huanwen,Xu, Binghe,Gao, Qinglei,Zhou, Xiaoyan,Shao, Jianyong...&Ma, Ding.(2021).Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China (vol 24, pg 715, 2020).MOLECULAR DIAGNOSIS & THERAPY,25,(2)
MLA：
Wu, Huanwen,et al."Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China (vol 24, pg 715, 2020)".MOLECULAR DIAGNOSIS & THERAPY 25..2(2021):267-268
